SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SPRC SciSparc Ltd.

Pre-Mkt 10-13 06:56:51 EDT

4.08

-0.39

-8.72%

High4.47	Low4.05	Vol10.81K
Open4.47	D1 Closing4.47	Amplitude9.40%
Mkt Cap2.37M	Tradable Cap2.29M	Total Shares581.00K
T/O45.19K	T/O Rate1.93%	Tradable Shares561.10K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SPRC","market":"US","secType":"STK","nameCN":"SciSparc Ltd.","latestPrice":4.08,"timestamp":1791835200000,"preClose":4.47,"halted":0,"volume":10805,"delay":0,"changeRate":-0.08724832214765094,"floatShares":561100,"shares":581000,"eps":-22.110056,"marketStatus":"Pre-Mkt","change":-0.39,"latestTime":"10-13 06:56:51 EDT","open":4.47,"high":4.47,"low":4.05,"amount":45192.674253,"amplitude":0.09396,"askPrice":4.16,"askSize":33,"bidPrice":3.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-22.110056,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"NASDAQ","adjPreClose":4.08,"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.08,"latestTime":"19:30 EDT","volume":550,"amount":2259.5934,"timestamp":1791847802907,"change":0.04,"changeRate":0.009804,"amplitude":0.009804},"volumeRatio":0.749015637825788},"requestUrl":"/m/hq/s/SPRC","defaultTab":"news","newsList":[{"id":"2673301865","title":"SciSparc Unit CliniQuantum Reports 16.8-Fold GPU Speedup in Quantum-Simulated Gene Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301865","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673301865?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:22","pubTimestamp":1791375734,"startTime":"0","endTime":"0","summary":"SciSparc unit CliniQuantum reports 16.8-fold GPU speedup in quantum-simulated gene analysisScisparc subsidiary NeuroThera Labs said majority-owned unit CliniQuantum achieved 16.8x faster quantum-simul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL4fYYpb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787422","title":"Scisparc Six-Month Net Loss Narrows to USD 6.05 Million; Revenue Falls 38% to USD 284,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787422","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787422?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:07","pubTimestamp":1790802453,"startTime":"0","endTime":"0","summary":"Scisparc six-month net loss narrows to USD 6.05 million; revenue falls 38% to USD 284,000SciSparc posted a net loss of USD 6.05 million for the six months ended June 30, 2026, narrowing from USD 9.41 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLbS0v1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672874247","title":"Scisparc Management Commentary Says H1 2026 Operating Loss Widens to USD 4.89 Million on Higher R&D, G&A Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874247?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:07","pubTimestamp":1790802438,"startTime":"0","endTime":"0","summary":"Scisparc management commentary says H1 2026 operating loss widens to USD 4.89 million on higher R&D, G&A costsManagement commentary from Scisparc covered the six months ended June 30, 2026, with reven","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL5S8VL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430486","title":"SciSparc expands U.S. IP portfolio in collaboration with Clearmind Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669430486?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:46","pubTimestamp":1790167561,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC) announced that NeuroThera Labs highlighted the expansion of the U.S. intellectual property, IP, portfolio through its ongoing colla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-expands-u-s-ip-portfolio-in-collaboration-with-clearmind-medicine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-expands-u-s-ip-portfolio-in-collaboration-with-clearmind-medicine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","NXTI","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664347811","title":"SciSparc Subsidiary NeuroThera Pursues FDA Orphan Drug Designation for Tourette Drug SCI-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347811","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347811?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:17","pubTimestamp":1788351435,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera pursues FDA orphan drug designation for Tourette drug SCI-110SciSparc subsidiary NeuroThera Labs began pursuing FDA orphan drug designation for SCI-110 in adult Tourette","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5DSJXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","IE00B64PRP62.GBP","BK4588","BK4139","BK4112","IE00BQXX3C00.GBP","BCDF","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4007","IE00BN0W2W23.USD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","SG9999014013.SGD","SPRC","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664113128","title":"Scisparc: Subsidiary Neurothera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm Rk Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=2664113128","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664113128?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:17","pubTimestamp":1788351420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA7PDRMY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883858","title":"SciSparc subsidiary provides update on SCI-210 trial enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883858","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883858?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207046,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC)announced that NeuroThera Labs continued advancement in participant enrollment for the clinical trial assessing NeuroThera’s SCI-210...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-subsidiary-provides-update-on-sci-210-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GDOC","MEDX","NVIB","HYLG","BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664434888","title":"SciSparc Subsidiary NeuroThera Labs Enrolls 26 Children in SCI-210 Autism Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664434888","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664434888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:03","pubTimestamp":1788206599,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera Labs enrolls 26 children in SCI-210 autism trialSciSparc’s subsidiary NeuroThera Labs accelerated enrollment in its SCI-210 pediatric autism trial, reaching 26 participa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL7lKvSL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4112","BK4588","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014039.USD","NDAQ","LU2095319765.USD","SPRC","BK4139","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888486","title":"Scisparc: Subsidiary Neurothera Labs Achieves Significant Enrollment Momentum in Sci‑210 Autism Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888486?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:03","pubTimestamp":1788206580,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA7QXZCY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084341","title":"Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084341","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084341?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:10","pubTimestamp":1787847015,"startTime":"0","endTime":"0","summary":"“Psychedelic” is The Fly’s recurring series focused on psychedelic stock news. SCISPARC/CLEARMIND: SciSparc (SPRC) announced earlier this week that...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-scisparc-clearmind-publish-patent-application-for-ptsd-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-scisparc-clearmind-publish-patent-application-for-ptsd-treatment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","USRD","SPRC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662592711","title":"SciSparc Adds AI Expert Carmel Domshlak to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2662592711","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662592711?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:32","pubTimestamp":1787747537,"startTime":"0","endTime":"0","summary":"SciSparc adds AI expert Carmel Domshlak to scientific advisory boardSciSparc named Technion professor Carmel Domshlak to its new Scientific Advisory Board for AI and Cybersecurity, effective Sept. 1, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL4H7Z12:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","BK4007","IE00BQXX3D17.EUR","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00BQXX3C00.GBP","SPRC","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","IE00BQXX3F31.USD","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661645271","title":"SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2661645271","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661645271?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:20","pubTimestamp":1787577613,"startTime":"0","endTime":"0","summary":"SciSparc (SPRC) announced that its subsidiary, NeuroThera Labs, and Clearmind Medicine (CMND) have published a U.S. patent application covering a n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scisparc-clearmind-publish-u-s-patent-application-for-mdma-pea-combination-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scisparc-clearmind-publish-u-s-patent-application-for-mdma-pea-combination-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SPRC","BK4007","USRD","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661182279","title":"Scisparc: Neurothera-Clearmind Collaboration Advances Mdma-N-Acylethanolamines Ip for the Treatment of Ptsd Amid Rising U.S. Federal Support for Psychedelic Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2661182279","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661182279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:51","pubTimestamp":1787575860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA2PY0RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660423634","title":"Scisparc Posts Audited 2025 Net Loss of USD 12.56 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660423634","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660423634?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:38","pubTimestamp":1787143122,"startTime":"0","endTime":"0","summary":"Scisparc posts audited 2025 net loss of USD 12.56 millionSciSparc filed an amended annual report with audited consolidated financial statements for the year ended Dec. 31, 2025.Net loss totaled USD 12","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL6l68RS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462566","title":"Scisparc: Subsidiary Neurothera Labs Completes C$5.4 Million Financing with Scisparc’s Stake Valued at Approximately C$30 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462566?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:06","pubTimestamp":1787054760,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUADSSSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659815183","title":"NeuroThera Labs Raises C$ 2.7 Million in First Tranche of Non-Brokered Private Placement at C$ 0.12 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2659815183","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659815183?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:01","pubTimestamp":1786568468,"startTime":"0","endTime":"0","summary":"NeuroThera Labs raises C$ 2.7 million in first tranche of non-brokered private placement at C$ 0.12 per unitNeuroThera Labs closed a first tranche of a non-brokered private placement, raising C$ 2.7 m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL8Sz66h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977842","title":"SciSparc Unit NeuroThera Labs Wins Japanese Patent for Paracetamol Combination Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977842?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:25","pubTimestamp":1786537545,"startTime":"0","endTime":"0","summary":"SciSparc unit NeuroThera Labs wins Japanese patent for paracetamol combination therapySciSparc unit NeuroThera Labs secured a Japanese patent covering a proprietary drug-combination platform aimed at ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL8fQBFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","BK4007","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SPRC","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658797789","title":"Scisparc’s Subsidiary Neurothera Labs Granted Japanese Patent for Its Proprietary, Innovative Therapeutic Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2658797789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658797789?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:25","pubTimestamp":1786537508,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44916E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544402","title":"SciSparc Subsidiary NeuroThera Launches Phase IIb Tourette Trial Site at Yale Child Study Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544402","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544402?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:22","pubTimestamp":1785932541,"startTime":"0","endTime":"0","summary":"SciSparc subsidiary NeuroThera launches Phase IIb Tourette trial site at Yale Child Study CenterSciSparc subsidiary NeuroThera Labs launched a U.S. Phase IIb trial site at Yale for SCI-110 in adult To","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL6B19Rb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","SPRC","BK4585","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014013.SGD","SG9999014005.SGD","BK4007","IE00B64PRP62.GBP","BK4588","SG9999014039.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4139","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544403","title":"Scisparc: Subsidiary Neurothera Labs Launches Phase Iib Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544403?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:22","pubTimestamp":1785932520,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA2VCJMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","SPRC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scisparc.com","stockEarnings":[{"period":"1week","weight":-0.0642},{"period":"1month","weight":-0.1969},{"period":"3month","weight":-0.0445},{"period":"6month","weight":0.2035},{"period":"1year","weight":-0.8869},{"period":"ytd","weight":-0.6667}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.075328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.14034},{"month":3,"riseRate":0,"avgChangeRate":-0.320237},{"month":4,"riseRate":0.4,"avgChangeRate":0.283936},{"month":5,"riseRate":0.6,"avgChangeRate":-0.008039},{"month":6,"riseRate":0,"avgChangeRate":-0.212405},{"month":7,"riseRate":0.2,"avgChangeRate":-0.13712},{"month":8,"riseRate":0,"avgChangeRate":-0.387718},{"month":9,"riseRate":0.2,"avgChangeRate":0.131969},{"month":10,"riseRate":0.6,"avgChangeRate":0.034937},{"month":11,"riseRate":0.5,"avgChangeRate":0.007929},{"month":12,"riseRate":0.25,"avgChangeRate":-0.09099}],"exchange":"NASDAQ","name":"SciSparc Ltd.","nameEN":"SciSparc Ltd.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SciSparc Ltd.(SPRC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SciSparc Ltd.,SPRC,SciSparc Ltd.股票,SciSparc Ltd.股票老虎,SciSparc Ltd.股票老虎国际,SciSparc Ltd.行情,SciSparc Ltd.股票行情,SciSparc Ltd.股价,SciSparc Ltd.股市,SciSparc Ltd.股票价格,SciSparc Ltd.股票交易,SciSparc Ltd.股票购买,SciSparc Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SciSparc Ltd.(SPRC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SciSparc Ltd.(SPRC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}